Only the best for your furry friends.
Dyne Therapeutics’ experimental treatment for Duchenne muscular dystrophy (DMD) showed promise in new data from a small Phase 1/2 trial dubbed DELIVER, the pharma announced this week. The drug, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results